KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medtronic (MDT) Revenue (2016 - 2025)

Historic Revenue for Medtronic (MDT) over the last 12 years, with Q4 2025 value amounting to $9.0 billion.

  • Medtronic's Revenue rose 664.05% to $9.0 billion in Q4 2025 from the same period last year, while for Oct 2025 it was $34.8 billion, marking a year-over-year increase of 534.0%. This contributed to the annual value of $33.5 billion for FY2025, which is 362.44% up from last year.
  • According to the latest figures from Q4 2025, Medtronic's Revenue is $9.0 billion, which was up 664.05% from $8.6 billion recorded in Q3 2025.
  • In the past 5 years, Medtronic's Revenue registered a high of $9.0 billion during Q4 2025, and its lowest value of $7.4 billion during Q3 2022.
  • Its 5-year average for Revenue is $8.1 billion, with a median of $8.0 billion in 2021.
  • As far as peak fluctuations go, Medtronic's Revenue surged by 3651.22% in 2021, and later plummeted by 771.25% in 2022.
  • Medtronic's Revenue (Quarter) stood at $7.8 billion in 2021, then decreased by 3.34% to $7.6 billion in 2022, then grew by 5.26% to $8.0 billion in 2023, then rose by 5.25% to $8.4 billion in 2024, then grew by 6.64% to $9.0 billion in 2025.
  • Its Revenue was $9.0 billion in Q4 2025, compared to $8.6 billion in Q3 2025 and $8.9 billion in Q2 2025.